In mammals, NADPH oxidase 4 is constitutively expressed in immune and epithelial cells, contributing to host defence as well as redox-sensitive signalling pathways, such as NF-κB, MAPK, and JNK—processes implicated in inflammation, fibrosis, and metabolic disease. Here, NOX4 is linked to metabolic disease.